Research Article
PLP2 Expression as a Prognostic and Therapeutic Indicator in High-Risk Multiple Myeloma
Table 2
Univariate and multivariate Cox regression analyses for OS in 87 NDMM patients.
| Variables | Univariate model | Multivariate model | | HR | 95% CI | | HR | 95% CI | |
| | 1.072 | 0.467-2.460 | 0.870 | | | | Male sex | 0.290 | 0.035-2.431 | 0.254 | | | | | 1.669 | 1.268-2.182 | 0.032 | 1.349 | 0.976-3.168 | 0.171 | | 0.567 | 0.192-1.672 | 0.304 | | | | | 3.561 | 1.643-6.154 | 0.015 | 2.592 | 1.129-5.611 | 0.010 | | 1.415 | 0.534-3.754 | 0.485 | | | | | 1.517 | 0.622-3.699 | 0.359 | | | | | 0.573 | 0.226-1.455 | 0.241 | | | | | 1.501 | 0.631-3.435 | 0.336 | | | | PLP2 ++ & +++ | 3.250 | 1.320-7.999 | 0.010 | 2.598 | 1.032-5.991 | 0.041 |
|
|